These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33922903)

  • 21.
    Montecino-Garrido H; Méndez D; Araya-Maturana R; Millas-Vargas JP; Wehinger S; Fuentes E
    Front Pharmacol; 2022; 13():893873. PubMed ID: 35645840
    [No Abstract]   [Full Text] [Related]  

  • 22. Characterization of a unique dihydropyrimidinone, ethyl 4-(4'-heptanoyloxyphenyl)-6-methyl-3,4-dihydropyrimidin-2-one-5-carboxylate, as an effective antithrombotic agent in a rat experimental model.
    Priya N; Singh P; Bhatia S; Medhi B; Prasad AK; Parmar VS; Raj HG
    J Pharm Pharmacol; 2011 Sep; 63(9):1175-85. PubMed ID: 21827490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guanosine exerts antiplatelet and antithrombotic properties through an adenosine-related cAMP-PKA signaling.
    Fuentes F; Alarcón M; Badimon L; Fuentes M; Klotz KN; Vilahur G; Kachler S; Padró T; Palomo I; Fuentes E
    Int J Cardiol; 2017 Dec; 248():294-300. PubMed ID: 28811090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa receptor antagonist.
    Mousa SA; Bozarth JM; Forsythe MS; Jackson SM; Leamy A; Diemer MM; Kapil RP; Knabb RM; Mayo MC; Pierce SK
    Circulation; 1994 Jan; 89(1):3-12. PubMed ID: 8281661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of platelet aggregation by some flavonoids.
    Tzeng SH; Ko WC; Ko FN; Teng CM
    Thromb Res; 1991 Oct; 64(1):91-100. PubMed ID: 1776142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity.
    Badimon JJ; Weng D; Chesebro JH; Fuster V; Badimon L
    Thromb Haemost; 1994 Apr; 71(4):511-6. PubMed ID: 8052972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiplatelet activity of epigallocatechin gallate is mediated by the inhibition of PLCgamma2 phosphorylation, elevation of PGD2 production, and maintaining calcium-ATPase activity.
    Jin YR; Im JH; Park ES; Cho MR; Han XH; Lee JJ; Lim Y; Kim TJ; Yun YP
    J Cardiovasc Pharmacol; 2008 Jan; 51(1):45-54. PubMed ID: 18209568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro effects of aprosulate sodium, a novel anticoagulant, on platelet activation: possible mechanism for antiplatelet action.
    Sugidachi A; Breiter N; Ogawa T; Asai F; Koike H
    Thromb Haemost; 1996 Nov; 76(5):786-90. PubMed ID: 8950791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiplatelet activity of green tea catechins is mediated by inhibition of cytoplasmic calcium increase.
    Kang WS; Chung KH; Chung JH; Lee JY; Park JB; Zhang YH; Yoo HS; Yun YP
    J Cardiovasc Pharmacol; 2001 Dec; 38(6):875-84. PubMed ID: 11707691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiplatelet and antithrombotic activities of CP201, a newly synthesized 1,4-naphthoquinone derivative.
    Jin YR; Hwang KA; Cho MR; Kim SY; Kim JH; Ryu CK; Son DJ; Park YH; Yun YP
    Vascul Pharmacol; 2004 Feb; 41(1):35-41. PubMed ID: 15135330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiplatelet effect of marchantinquinone, isolated from Reboulia hemisphaerica, in rabbit washed platelets.
    Liao CH; Ko FN; Wu CL; Teng CM
    J Pharm Pharmacol; 2000 Mar; 52(3):353-9. PubMed ID: 10757426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of effects of various drugs on platelet functions using phorbol 12-myristate 13-acetate-induced megakaryocytic human erythroid leukemia cells.
    Tada T; Aki K; Oboshi W; Kawazoe K; Yasui T; Hosoi E
    Drug Des Devel Ther; 2016; 10():3099-3107. PubMed ID: 27713620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The in-vitro effects of E5555, a protease-activated receptor (PAR)-1 antagonist, on platelet biomarkers in healthy volunteers and patients with coronary artery disease.
    Serebruany VL; Kogushi M; Dastros-Pitei D; Flather M; Bhatt DL
    Thromb Haemost; 2009 Jul; 102(1):111-9. PubMed ID: 19572075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antithrombotic activity of Vitis labrusca extract on rat platelet aggregation.
    Kwon SU; Lee HY; Xin M; Ji SJ; Cho HK; Kim DS; Kim DK; Lee YM
    Blood Coagul Fibrinolysis; 2016 Mar; 27(2):141-6. PubMed ID: 26340455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiplatelet and antithrombotic effects of platelet glycoprotein IIb/IIIa (GPIIb/IIIa) inhibition by arginine-glycine-aspartic acid-serine (RGDS) and arginine-glycine-aspartic acid (RGD) (O-me)Y (SC-46749).
    Nicholson NS; Panzer-Knodle SG; Salyers AK; Taite BB; King LW; Miyano M; Gorczynski RJ; Williams MH; Zupec ME; Tjoeng FS
    J Pharmacol Exp Ther; 1991 Mar; 256(3):876-82. PubMed ID: 2005585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of antiplatelet drugs in vitro: aspirin, iloprost, and the nitric oxide donors SIN-1 and sodium nitroprusside.
    Negrescu EV; Grünberg B; Kratzer MA; Lorenz R; Siess W
    Cardiovasc Drugs Ther; 1995 Aug; 9(4):619-29. PubMed ID: 8547213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitory mechanism of human platelet aggregation by nafamostat mesilate.
    Fuse I; Higuchi W; Toba K; Aizawa Y
    Platelets; 1999 Jul; 10(4):212-8. PubMed ID: 16801094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiplatelet activity of BRX-018, (6aS,cis)-malonic acid 3-acetoxy-6a9-bis-(2-methoxycarbonyl-acetoxy)-6,6a,7,11b-tetrahydro-indeno[2,1-c]chromen-10-yl ester methylester.
    Lee GY; Chang TS; Lee KS; Khil LY; Kim D; Chung JH; Kim YC; Lee BH; Moon CH; Moon CK
    Thromb Res; 2005; 115(4):309-18. PubMed ID: 15668191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extracts from Trifolium pallidum and Trifolium scabrum aerial parts as modulators of blood platelet adhesion and aggregation.
    Kolodziejczyk-Czepas J; Olas B; Malinowska J; Wachowicz B; Szajwaj B; Kowalska I; Oleszek W; Stochmal A
    Platelets; 2013; 24(2):136-44. PubMed ID: 22646735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thromboxane A2 synthase inhibition and thromboxane A2 receptor blockade by 2-[(4-cyanophenyl)amino]-3-chloro-1,4-naphthalenedione (NQ-Y15) in rat platelets.
    Chang TS; Kim HM; Lee KS; Khil LY; Mar WC; Ryu CK; Moon CK
    Biochem Pharmacol; 1997 Jul; 54(2):259-68. PubMed ID: 9271330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.